Quantitative CT-derived vessel metrics in idiopathic pulmonary fibrosis: A structure-function study

被引:29
作者
Jacob, Joseph [1 ,2 ]
Pienn, Michael [3 ]
Payer, Christian [4 ]
Urschler, Martin [4 ,5 ]
Kokosi, Maria [6 ]
Devaraj, Anand [7 ]
Wells, Athol U. [6 ]
Olschewski, Horst [3 ,8 ]
机构
[1] UCL, Dept Resp Med, London, England
[2] UCL, Ctr Med Image Comp, London, England
[3] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria
[4] Graz Univ Technol, Inst Comp Graph & Vis, Graz, Austria
[5] Ludwig Boltzmann Inst Clin Forens Imaging, Graz, Austria
[6] Royal Brompton Hosp, Interstitial Lung Dis Unit, Fulham Rd Wing, London SW3 6JY, England
[7] Royal Brompton Hosp, Dept Radiol, London, England
[8] Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria
基金
奥地利科学基金会; 英国惠康基金;
关键词
interstitial lung disease; lung fibrosis; radiology and other imaging; respiratory structure and function; COMPUTED-TOMOGRAPHY; DIAGNOSIS; SURVIVAL;
D O I
10.1111/resp.13485
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective This study aimed to investigate whether quantitative lung vessel morphology determined by a new fully automated algorithm is associated with functional indices in idiopathic pulmonary fibrosis (IPF). Methods A total of 152 IPF patients had vessel volume, density, tortuosity and heterogeneity quantified from computed tomography (CT) images by a fully automated algorithm. Separate quantitation of vessel metrics in pulmonary arteries and veins was performed in 106 patients. Results were evaluated against readouts from lung function tests. Results Normalized vessel volume expressed as a percentage of total lung volume was moderately correlated with functional indices on univariable linear regression analysis: forced vital capacity (R-2 = 0.27, P < 1 x 10(-6)), diffusion capacity for carbon monoxide (DLCO; R-2 = 0.12, P = 3 x 10(-5)), total lung capacity (TLC; R-2 = 0.45, P < 1 x 10(-6)) and composite physiologic index (CPI; R-2 = 0.28, P < 1 x 10(-6)). Normalized vessel volume was correlated with vessel density but not with vessel heterogeneity. Quantitatively derived vessel metrics (and artery and vein subdivision scores) were not significantly linked with the transfer factor for carbon monoxide (K-CO), and only weakly with DLCO. On multivariable linear regression analysis, normalized vessel volume and vessel heterogeneity were independently linked with DLCO, TLC and CPI indicating that they capture different aspects of lung damage. Artery-vein separation provided no additional information beyond that captured in the whole vasculature. Conclusion Our study confirms previous observations of links between vessel volume and functional measures of disease severity in IPF using a new vessel quantitation tool. Additionally, the new tool shows independent linkages of normalized vessel volume and vessel heterogeneity with functional indices. Quantitative vessel metrics do not appear to reflect vasculopathic damage in IPF.
引用
收藏
页码:445 / 452
页数:8
相关论文
共 22 条
[1]  
[Anonymous], 2015, C66 LUNG IMAGING 2 N, DOI [10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4975., DOI 10.1164/AJRCCM-CONFERENCE.2015.191.1_MEETINGABSTRACTS.A4975]
[2]   Measuring tortuosity of the intracerebral vasculature from MRA images [J].
Bullitt, E ;
Gerig, G ;
Pizer, SM ;
Lin, WL ;
Aylward, SR .
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2003, 22 (09) :1163-1171
[3]   Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility [J].
Chin, Matthew ;
Johns, Christopher ;
Currie, Benjamin J. ;
Weatherley, Nicholas ;
Hill, Catherine ;
Elliot, Charlie ;
Rajaram, Smitha ;
Wild, Jim M. ;
Condliffe, Robin ;
Bianchi, Stephen ;
Kiely, David G. ;
Swift, Andrew J. .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
[4]   Radiological versus histological diagnosis in UIP and NSIP: survival implications [J].
Flaherty, KR ;
Thwaite, EL ;
Kazerooni, EA ;
Gross, BH ;
Toews, GB ;
Colby, TV ;
Travis, WD ;
Mumford, JA ;
Murray, S ;
Flint, A ;
Lynch, JP ;
Martinez, FJ .
THORAX, 2003, 58 (02) :143-148
[5]   Quantification of Tortuosity and Fractal Dimension of the Lung Vessels in Pulmonary Hypertension Patients [J].
Helmberger, Michael ;
Pienn, Michael ;
Urschler, Martin ;
Kullnig, Peter ;
Stollberger, Rudolf ;
Kovacs, Gabor ;
Olschewski, Andrea ;
Olschewski, Horst ;
Balint, Zoltan .
PLOS ONE, 2014, 9 (01)
[6]   Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis [J].
Jacob, Joseph ;
Bartholmai, Brian J. ;
Rajagopalan, Srinivasan ;
van Moorsel, Coline H. M. ;
van Es, Hendrik W. ;
van Beek, Frouke T. ;
Struik, Marjolijn H. L. ;
Kokosi, Maria ;
Egashira, Ryoko ;
Brun, Anne Laure ;
Nair, Arjun ;
Walsh, Simon L. F. ;
Cross, Gary ;
Barnett, Joseph ;
de lauretis, Angelo ;
Judge, Eoin P. ;
Desai, Sujal ;
Karwoski, Ronald ;
Ourselin, Sebastien ;
Renzoni, Elisabetta ;
Maher, Toby M. ;
Altmann, Andre ;
Wells, Athol U. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (06) :767-776
[7]   Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures [J].
Jacob, Joseph ;
Bartholmai, Brian J. ;
Rajagopalan, Srinivasan ;
Kokosi, Maria ;
Nair, Arjun ;
Karwoski, Ronald ;
Walsh, Simon L. F. ;
Wells, Athol U. ;
Hansell, David M. .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (01)
[8]   Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function [J].
Jacob, Joseph ;
Bartholmai, Brian J. ;
Rajagopalan, Srinivasan ;
Kokosi, Maria ;
Nair, Arjun ;
Karwoski, Ronald ;
Raghunath, Sushravya M. ;
Walsh, Simon L. F. ;
Wells, Athol U. ;
Hansell, David M. .
JOURNAL OF THORACIC IMAGING, 2016, 31 (05) :304-311
[9]   Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months [J].
Kim, Hyun J. ;
Brown, Matthew S. ;
Chong, Daniel ;
Gjertson, David W. ;
Lu, Peiyun ;
Kim, Hak J. ;
Coy, Heidi ;
Goldin, Jonathan G. .
ACADEMIC RADIOLOGY, 2015, 22 (01) :70-80
[10]   A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis [J].
King, Talmadge E., Jr. ;
Bradford, Williamson Z. ;
Castro-Bernardini, Socorro ;
Fagan, Elizabeth A. ;
Glaspole, Ian ;
Glassberg, Marilyn K. ;
Gorina, Eduard ;
Hopkins, Peter M. ;
Kardatzke, David ;
Lancaster, Lisa ;
Lederer, David J. ;
Nathan, Steven D. ;
Pereira, Carlos A. ;
Sahn, Steven A. ;
Sussman, Robert ;
Swigris, Jeffrey J. ;
Noble, Paul W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2083-2092